# Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients

> **NCT01709994** · PHASE3 · UNKNOWN · sponsor: **Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales** · enrollment: 97 (estimated)

## Conditions studied

- Chronic Kidney Disease Stage 4
- Chronic Kidney Disease Stage 3

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT01709994
- **Lead sponsor:** Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709994, "Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01709994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*